相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression
Pradeep S. Tanwar et al.
CARCINOGENESIS (2013)
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer
Cristina Ivan et al.
GYNECOLOGIC ONCOLOGY (2013)
Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression
Mamadou Keita et al.
GYNECOLOGIC ONCOLOGY (2013)
New insights into the role of Runx1 in epithelial stem cell biology and pathology
Cornelia Johanna Franziska Scheitz et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
MMPs in Ovarian Cancer as Therapeutic Targets
Amer Karam et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis
Austin M. Dulak et al.
CANCER RESEARCH (2012)
Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract
Remond J. A. Fijneman et al.
CANCER SCIENCE (2012)
RUNX3 interactome reveals novel centrosomal targeting of RUNX family of transcription factors
Linda Shyue Huey Chuang et al.
CELL CYCLE (2012)
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype
Francesca Ricci et al.
CELL CYCLE (2012)
Murine models of ovarian cancer for preclinical testing of targeted therapeutics Has their time arrived?
Kathleen R. Cho
CELL CYCLE (2012)
Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer
Cornelia Johanna Franziska Scheitz et al.
EMBO JOURNAL (2012)
Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer
Ahmed Elattar et al.
GYNECOLOGIC ONCOLOGY (2012)
Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer
Weiping Li et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo?
Cinzia Baranello et al.
PLOS ONE (2012)
SPARC Is a Key Regulator of Proliferation, Apoptosis and Invasion in Human Ovarian Cancer
Jie Chen et al.
PLOS ONE (2012)
Optimized anti-tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule
Harald Ehrhardt et al.
BLOOD (2011)
Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and risk of colon and rectal cancer: additional support for a TGF-β-signaling pathway
Martha L. Slattery et al.
CARCINOGENESIS (2011)
RUNX1 and its understudied role in breast cancer
Kevin A. Janes
CELL CYCLE (2011)
The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling
Silvia Zecchini et al.
EMBO MOLECULAR MEDICINE (2011)
RUNX3 functions as an oncogene in ovarian cancer
Cecilia Wei Lin Lee et al.
GYNECOLOGIC ONCOLOGY (2011)
Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma
Jesus Planaguma et al.
HUMAN PATHOLOGY (2011)
Activating transcription factor 3 (ATF3) promotes sublytic C5b-9-induced glomerular mesangial cells apoptosis through up-regulation of Gadd45α and KLF6 gene expression
Kuanfeng Xu et al.
IMMUNOBIOLOGY (2011)
Interplay of transcription factors in T-cell differentiation and function: the role of Runx
Won Fen Wong et al.
IMMUNOLOGY (2011)
Significance of Cell Cycle Regulatory Proteins as Malignant and Prognostic Biomarkers in Ovarian Epithelial Tumors
Yoon Hee Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling
Renato V. Iozzo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
Karen McLean et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer
Pierre-Luc Mercier et al.
MOLECULAR ONCOLOGY (2011)
Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease
I. Plante et al.
ONCOGENE (2011)
Progression-Free Survival in Ovarian Cancer Is Reflected in Epigenetic DNA Methylation Profiles
Dirk O. Bauerschlag et al.
ONCOLOGY (2011)
Runx family genes, niche, and stem cell quiescence
Chelsia Qiuxia Wang et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Upregulation of DLX5 Promotes Ovarian Cancer Cell Proliferation by Enhancing IRS-2-AKT Signaling
Yinfei Tan et al.
CANCER RESEARCH (2010)
Runx Regulation of Sphingolipid Metabolism and Survival Signaling
Anna Kilbey et al.
CANCER RESEARCH (2010)
TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy
Jian-Liang Chou et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
First-line treatment of advanced ovarian cancer: current research and perspectives
Claudia Marchetti et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors
Yuanguang Meng et al.
BMC CANCER (2009)
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
Meng Li et al.
BMC MEDICAL GENOMICS (2009)
Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency
Hsiang-Yuan Yeh et al.
BMC MEDICAL GENOMICS (2009)
14-3-3σ and p21 synergize to determine DNA damage response following Chk2 inhibition
Shasha Meng et al.
CELL CYCLE (2009)
Epigenetic Changes in Ovarian Cancer
Curt Balch et al.
ENDOCRINOLOGY (2009)
An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasis
Andreas Doll et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
RUNX3 Gene Methylation in Epithelial Ovarian Cancer Tissues and Ovarian Cancer Cell Lines
Shiqian Zhang et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2009)
RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress
K. Wolyniec et al.
ONCOGENE (2009)
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
Bharat B. Aggarwal et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids
Sylvain L'Esperance et al.
BMC GENOMICS (2008)
DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage
George S. Watts et al.
BMC MEDICAL GENOMICS (2008)
MEIS and PBX homeobox proteins in ovarian cancer
A. P. G. Crijns et al.
EUROPEAN JOURNAL OF CANCER (2007)
Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells
J. Li et al.
ONCOGENE (2007)
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells
Jaime Symowicz et al.
CANCER RESEARCH (2007)
Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells
A. Rivera et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
ATF3 regulates the stability of p53 - A link to cancer
Chunhong Yan et al.
CELL CYCLE (2006)
Normal and transforming functions of RUNX1: A perspective
FM Mikhail et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Genomic models of metastatic cancer - Functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated polycomb group (PcG) protein chromatin silencing pathway
GV Glinsky
CELL CYCLE (2006)
Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
M Yanagida et al.
ONCOGENE (2005)
The RUNX genes: Gain or loss of function in cancer
K Blyth et al.
NATURE REVIEWS CANCER (2005)
Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling
V Syed et al.
ONCOGENE (2005)
Identifying DNA methylation biomarkers of cancer drug response
S Maier et al.
AMERICAN JOURNAL OF PHARMACOGENOMICS (2005)
oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes
SJH Sui et al.
NUCLEIC ACIDS RESEARCH (2005)
Decreased expression of 14-3-3σ is associated with advanced disease in human epithelial ovarian cancer:: Its correlation with aberrant DNA methylation
J Akahira et al.
CLINICAL CANCER RESEARCH (2004)
NF-κB-mediated repression of growth arrest- and DNA-damage-inducible proteins 45α and γ is essential for cancer cell survival
LF Zerbini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
DNA demethylation and cancer: therapeutic implications
M Szyf et al.
CANCER LETTERS (2004)
A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma
J Planagumà et al.
CANCER RESEARCH (2004)
RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53
SF Wotton et al.
ONCOGENE (2004)
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis
KH Lu et al.
CLINICAL CANCER RESEARCH (2004)
Wnt-signalling pathway in ovarian epithelial tumours:: increased expression of β-catenin and GSK3β
K Rask et al.
BRITISH JOURNAL OF CANCER (2003)
Oncogenic pathways implicated in ovarian epithelial cancer
SV Nicosia et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2003)
RGD peptides released from βig-h3, a TGF-β-induced cell-adhesive molecule, mediate apoptosis
JE Kim et al.
ONCOGENE (2003)
The prodomain of interleukin 1α interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells
AS Pollock et al.
FASEB JOURNAL (2003)
Coexpression of calcitonin receptor-like receptor and receptor activity-modifying protein 2 or 3 mediates the antimigratory effect of adrenomedullin
N Fukai et al.
ENDOCRINOLOGY (2003)
New mechanisms of AML1 gene alteration in hematological malignancies
C Roumier et al.
LEUKEMIA (2003)
Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome
HM Robinson et al.
LEUKEMIA (2003)
Core-binding factors in haematopoiesis and leukaemia
NA Speck et al.
NATURE REVIEWS CANCER (2002)
The t(8;21) fusion protein, AML1-ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia
B Linggi et al.
NATURE MEDICINE (2002)
Inactivation of 14-3-3σ influences telomere behavior and ionizing radiation-induced chromosomal instability
S Dhar et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Re: New guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]
I Vergote et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression
C Laronga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
